Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR

Breast tumors lacking expression of human epidermal growth factor receptor 2 (HER2) and the estrogen and the progesterone receptors (triple negative; TNBC) are more aggressive than other disease subtypes, and no molecular targeted agents are currently available for their treatment. Because TNBC comm...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ferraro, Daniela A., Gaborit, Nadège, Maron, Ruth, Cohen-Dvashi, Hadas, Porat, Ziv, Pareja, Fresia, Lavi, Sara, Lindzen, Moshit, Ben-Chetrit, Nir, Sela, Michael, Yarden, Yosef
פורמט: Artigo
שפה:Inglês
יצא לאור: National Academy of Sciences 2013
נושאים:
Biological Sciences
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3562774/
https://ncbi.nlm.nih.gov/pubmed/23319610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1220763110
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים